Cafepharma Today

April 18 2019 - ViiV and Gilead top 2018 pharma reputation survey
ViiV and Gilead top 2018 pharma reputation survey
BI chief regrets Brexit
Amazon’s healthcare ambitions
KCI Files for $100 Million IPO
*please scroll down for all the latest news*
*scroll through previous pages at the bottom to get older news*

NEW board: ASK A WHISTLEBLOWER ATTORNEY
Today's most popular searches:

Current News

submit a press release
SPOTLIGHT on: CP's Therapeutic Specialties Messageboards
AbbVie (ABBV) Earnings Expected to Grow
NASDAQ
Thursday, April 18, 2019 - 10:39pm
tags:
AbbVie, earnings
Lower dose of Pfizer-Lilly painkiller misses main goals in late stage study
Yahoo/Reuters
Thursday, April 18, 2019 - 10:35pm
tags:
Pfizer, Eli Lilly, clinical trials, painkillers, osteoarthritis of the knee, tanezumab
Microbiome Report for Week Ending 4/13/19
CP Wire
Thursday, April 18, 2019 - 10:33pm
tags:
MaaT Pharma, MaaT013, aGvHD, Second Genome, SkinBio Therapeutics, Azitram AZT-02, Netherton Syndrome
Clovis Focuses on Rubraca Label Expansion, Competition Stiff
Yahoo/Zacks.com
Thursday, April 18, 2019 - 10:25pm
tags:
Clovis Oncology, Rubraca, ovarian cancer
Bristol-Myers Squibb (BMY) Reports Next Week: Wall Street Expects Earnings Growth
Yahoo/Zacks.com
Thursday, April 18, 2019 - 10:23pm
tags:
Bristol-Myers Squibb, earnings
CBER Director Notes FY 2018 Accomplishments, Including Approval of Two Gene Therapies
BioSpace
Thursday, April 18, 2019 - 10:14pm
tags:
FDA, CBER, gene therapy
FDA draft guidance suggests comparing bispecifics to monospecific antibodies
BioCentury
Thursday, April 18, 2019 - 10:13pm
tags:
FDA, bispecific antibodies
St. Jude’s Gene Therapy Appears to Cure “Bubble Boy Disease”
BioSpace
Thursday, April 18, 2019 - 10:11pm
tags:
gene therapy, SXCID, bubble boy syndrome, clinical trials
Drugmakers Reveal List Prices Online After Pressure From Trump
Bloomberg
Thursday, April 18, 2019 - 10:10pm
tags:
drug pricing, Donald Trump
HIV drugmakers ViiV, Gilead top 2018 pharma reputation survey
Fierce Pharma
Thursday, April 18, 2019 - 11:07am
tags:
reputation, Gilead Sciences, ViiV
BI chief “regrets” Brexit, but continues to invest in UK
Pharmaforum
Thursday, April 18, 2019 - 11:05am
tags:
UK, Brexit, Boehringer Ingelheim
A biotech startup’s lofty goal: Kill cancer with pills that target RNA instead of proteins
Stat
Thursday, April 18, 2019 - 11:04am
tags:
Arrakis Therapeutics, RNA, cancer
Genfit bags FDA breakthrough tag on route to phase 3 in PBC
Fierce Biotech
Thursday, April 18, 2019 - 10:21am
tags:
Genfit, FDA, primary biliary cholangitis, elafibranor, clinical trials
Gilead-partnered Vienna-based immunotherapy company Hookipa makes Nasdaq debut with downsized $84M IPO
Endpoints
Thursday, April 18, 2019 - 10:13am
tags:
Hookipa, Gilead Sciences, IPOs
KCI Files for $100 Million IPO
CP Wire
Thursday, April 18, 2019 - 10:10am
tags:
KCI, devices, wound care, IPOs
Acticor's blood thinner cuts hemorrhage risk in human study, could offer hope for acute stroke
Fierce Biotech
Thursday, April 18, 2019 - 9:57am
tags:
Acticor, blood thinners, stroke
PureTech, Boehringer partner to develop lymph node-targeting cancer immunotherapies
BioCentury
Thursday, April 18, 2019 - 9:50am
tags:
Boehringer Ingelheim, PureTech, lymphatic targeting, GI cancers
Alexa: Tell me about Amazon’s ambitions in healthcare
Pharmaforum
Thursday, April 18, 2019 - 9:49am
tags:
Amazon, Alexa
COPD space about to have another drug
Bizjournals
Thursday, April 18, 2019 - 9:47am
tags:
Circassia, COPD, Duaklir Pressair, FDA
Idorsia confirms 2019 spending plan as clinical trials "on track"
Yahoo/Reuters
Thursday, April 18, 2019 - 9:44am
tags:
Idorsia, clinical trials

Pages

Latest CP Wire Articles

Microbiome Report for Week Ending 4/13/19
KCI Files for $100 Million IPO
Biomica Initiates Microbiome Based Immuno-Oncology Studies
Flagship Pioneering Unveils Microbiome Focused Kintai Therapeutics
Clinical-Stage Neurodegenerative Disease Company Files for $86 Million IPO
Microbiome Report for Week Ending 4/6/19
Axcella Health Files for $86 Million IPO
MaaT Pharma Announces Second Positive DSMB Safety Assessment of Ph II Study in Acute GvHD
Azitra Demonstrates Feasibility of Using the Skin Microbiome to Treat Skin Conditions
Company Brings Augmented Reality to Physician Detailing

Latest Pharmagather Articles

Enough With the Mouse Behavioral Models?
In the Pipeline
The Road to 2020: Understanding the Regulatory Timeline for Part D Rebate Reform
Drug Channels
Working together to get the best out of AI for all
Elsevier
Flipping Through the Pages
In the Pipeline
STP: Powering Marketing Success
pharmexec marketing
Rare Disease Innovation and Partnering Summit
Drug Channels
Beacon Discovery Leverages Partnerships and Elsevier Solutions to Further GCPR R&D Related Research
Elsevier
Accelerating Pre-clinical Development with Extracted Regulatory Data with PharmaPendium
Elsevier
Making Some New Compounds, to Fit Some New Receptors
In the Pipeline
Pharma Jobs from Indeed


Pharma and Device News from NASDAQ

Organovo to Present at 2019 Cell & Gene Meeting on the Mediterranean
Wednesday, April 17, 2019 - 8:05am
Radius Health to Present Two Posters at AACE 2019 Annual Meeting
Wednesday, April 17, 2019 - 8:00am
LifeVantage to Announce Third Quarter Fiscal Year 2019 Results on May 1, 2019
Wednesday, April 17, 2019 - 8:00am
Myriad Genetics Named to Forbes 2019 List of America's Best Midsize Employers and the Women Tech Council’s 2019 Shatter List
Wednesday, April 17, 2019 - 7:05am
Adverum Biotechnologies to Present New Preclinical Data on ADVM-022 Gene Therapy for Wet AMD at ASGCT and ARVO
Tuesday, April 16, 2019 - 4:00pm
Seelos Therapeutics to Participate at the Jefferies 2019 Global Healthcare Conference in NYC
Tuesday, April 16, 2019 - 8:00am
Cord Blood Banking Leader Cryo-Cell Reports Fiscal First Quarter 2019 Financial Results
Monday, April 15, 2019 - 4:15pm
MSI Methylation Sciences, Inc. (MSI) Update on Recent BC Supreme Court Order for Quark Venture Inc. (Quark) to Pay MSI $20 million USD
Monday, April 15, 2019 - 4:00pm
Adverum Biotechnologies Provides Clinical Program Update on ADVM-022 Gene Therapy for Wet AMD
Monday, April 15, 2019 - 9:00am
Axsome Therapeutics Announces AXS-05 Achieves Primary Endpoint in Phase 2 Trial in Smoking Cessation
Monday, April 15, 2019 - 6:00am

Breaking Healthcare News - powered by Seeking Alpha

IMAC Holdings reports FY results
Wednesday, April 17, 2019 - 8:35am
Bristol-Myers launches exchange offer for Celgene debt
Wednesday, April 17, 2019 - 8:33am
Revive Therapeutics nabs a patent for cannabinoid delivery system in U.S.
Wednesday, April 17, 2019 - 8:31am
TherapeuticsMD's BIJUVA now available in U.S.
Wednesday, April 17, 2019 - 8:29am
Abbott up 1% premarket on Q1 beat
Wednesday, April 17, 2019 - 8:11am
AveXis' Zolgensma shows positive effect in late-stage SMA study
Wednesday, April 17, 2019 - 8:03am
TherapeuticsMD +7% on signing $300M term loan financing facility with TSSP
Wednesday, April 17, 2019 - 7:51am
Aurora Cannabis to acquire rest of Hempco
Tuesday, April 16, 2019 - 9:34am
Biomerica misses by $0.02, misses on revenue
Tuesday, April 16, 2019 - 9:28am
Ultragenyx nabs accelerated review status in U.S. for UX007 for LC-FAOD
Tuesday, April 16, 2019 - 9:23am

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.